Northwest Biotherapeutics

CompanyUnited States

Northwest Biotherapeutics develops one asset. Mostly vaccine; based in the United States.

1
Asset
Furthest stage
Not known
0
Trials
1
Signal

Pipeline

1
  • DCVax-L

    Autologous dendritic cells loaded with tumor lysate stimulate an immune response against tumor antigens.

    Stage not known, Vaccine

Full company profiles: pipeline, trials, funding and people.

See Pro

In the full profile

  • Trials2
  • Signals1

Intelligence